Clinical TrialsAelis Farma Phase 2b Trial of AEF0217 Clears First IDMC Safety Review in Do... Aelis Farma Phase 2b Trial of AEF0217 Clears First IDMC Safety Review in Do... Read Post »
Clinical TrialsKairos Reports Favorable Safety Data for ENV-105 Plus Osimertinib in EGFR-M... Kairos Reports Favorable Safety Data for ENV-105 Plus Osimertinib in EGFR-M... Read Post »
Clinical TrialsInsmed Report Positive 12-Month Data from the OLE Study of Treprostinil Pal... Insmed Report Positive 12-Month Data from the OLE Study of Treprostinil Pal... Read Post »
Clinical TrialsChimeric Therapeutics Reports New Tumor Shrinkage Data with CHM CDH17 CAR-T... Chimeric Therapeutics Reports New Tumor Shrinkage Data with CHM CDH17 CAR-T... Read Post »
Clinical TrialsORIC Initiates Global Phase 3 Himalayas-1 Trial of Rinzimetostat Plus Darol... ORIC Initiates Global Phase 3 Himalayas-1 Trial of Rinzimetostat Plus Darol... Read Post »
Clinical TrialsBPGbio’s BPM31510 Shows Encouraging Survival Signal in Phase 2 Glioblasto... BPGbio’s BPM31510 Shows Encouraging Survival Signal in Phase 2 Glioblasto... Read Post »
Clinical TrialsAllogene’s ALLO-316 Shows 31% Response Rate in CD70-High Advanced Kidney ... Allogene’s ALLO-316 Shows 31% Response Rate in CD70-High Advanced Kidney ... Read Post »
Clinical TrialsBiogen and Eisai Present LEADER Study Results for LEQEMBI at AAIC 2026 Biogen and Eisai Present LEADER Study Results for LEQEMBI at AAIC 2026 Read Post »
Clinical TrialsKelun-Biotech Reports Positive Phase III OptiTROP-Lung06 Results in NSCLC Kelun-Biotech Reports Positive Phase III OptiTROP-Lung06 Results in NSCLC Read Post »
Clinical TrialsJAMA Publishes Phase 2 Ceperognastat Trial Results in Early Alzheimer’... JAMA Publishes Phase 2 Ceperognastat Trial Results in Early Alzheimer’... Read Post »
Clinical TrialsMediPharm Reports Positive Phase 2 LiBBY Results for Oral Cannabinoid Thera... MediPharm Reports Positive Phase 2 LiBBY Results for Oral Cannabinoid Thera... Read Post »
Clinical TrialsBiogen Advances Diranersen to Phase 3 After Positive CELIA Data Biogen Advances Diranersen to Phase 3 After Positive CELIA Data Read Post »
Clinical TrialsImmutep Reports 30.9-Month Overall Survival in Phase I INSIGHT-003 Trial of... Immutep Reports 30.9-Month Overall Survival in Phase I INSIGHT-003 Trial of... Read Post »
Clinical TrialsHemab Reports Durable Phase 2 Results for Sutacimig in Glanzmann Thrombasth... Hemab Reports Durable Phase 2 Results for Sutacimig in Glanzmann Thrombasth... Read Post »
Clinical TrialsDefinium Study Shows High Treatment Discontinuation in Generalized Anxiety ... Definium Study Shows High Treatment Discontinuation in Generalized Anxiety ... Read Post »
Clinical TrialsEisai Presents Findings Showing Etalanetug Reduced Alzheimer’s Tau Ta... Eisai Presents Findings Showing Etalanetug Reduced Alzheimer’s Tau Ta... Read Post »
Clinical TrialsOncolytics Advances Pelareorep Toward Registration in Metastatic Colorectal... Oncolytics Advances Pelareorep Toward Registration in Metastatic Colorectal... Read Post »
Clinical TrialsANI Reports Positive Results for ILUVIEN in Chronic Posterior Uveitis ANI Reports Positive Results for ILUVIEN in Chronic Posterior Uveitis Read Post »
Clinical TrialsCadrenal Reports Phase 2 CAD-1005 Data Showing Reduced Thrombotic Events in... Cadrenal Reports Phase 2 CAD-1005 Data Showing Reduced Thrombotic Events in... Read Post »
Clinical TrialsHemab Reports Positive HMB-002 Results, Introduces HMB-003 at ISTH 2026 Hemab Reports Positive HMB-002 Results, Introduces HMB-003 at ISTH 2026 Read Post »
Clinical TrialsAlixorexton Shows Sustained Wakefulness and Daytime Sleepiness Benefits for... Alixorexton Shows Sustained Wakefulness and Daytime Sleepiness Benefits for... Read Post »
Clinical TrialsQ32 Bio Reports Positive Phase 2 Results for Bempikibart in Alopecia Areata Q32 Bio Reports Positive Phase 2 Results for Bempikibart in Alopecia Areata Read Post »
Clinical TrialsGSK’s Jemperli Phase II Trial Shows Durable Complete Responses in dMMR Re... GSK’s Jemperli Phase II Trial Shows Durable Complete Responses in dMMR Re... Read Post »
Clinical TrialsLifestyle Intervention Improves Cognitive Function in Older Adults at Risk ... Lifestyle Intervention Improves Cognitive Function in Older Adults at Risk ... Read Post »
Clinical TrialsAAIC 2026: Subcutaneous LEQEMBI Matches IV Therapy in Early Alzheimer’... AAIC 2026: Subcutaneous LEQEMBI Matches IV Therapy in Early Alzheimer’... Read Post »
Clinical TrialsIN8bio Publishes Phase 1 INB-200 Glioblastoma Data in JCO Showing Survival ... IN8bio Publishes Phase 1 INB-200 Glioblastoma Data in JCO Showing Survival ... Read Post »
Clinical TrialsNovo Nordisk Reports Positive Results for Denecimig and Concizumab Novo Nordisk Reports Positive Results for Denecimig and Concizumab Read Post »
Clinical TrialsAB Science Discontinues Three Masitinib Trials to Prioritize ALS Phase III ... AB Science Discontinues Three Masitinib Trials to Prioritize ALS Phase III ... Read Post »
Clinical TrialsBausch + Lomb Discontinues BL1107 Eye Drops Following Phase 2 Glaucoma Fail... Bausch + Lomb Discontinues BL1107 Eye Drops Following Phase 2 Glaucoma Fail... Read Post »
Clinical TrialsRisvutatug Rezetecan Improves Survival in Phase III ARTEMIS-008 Trial, Mark... Risvutatug Rezetecan Improves Survival in Phase III ARTEMIS-008 Trial, Mark... Read Post »
Clinical TrialsRoche Discontinues Tominersen and RG6496 Development for Huntington’s... Roche Discontinues Tominersen and RG6496 Development for Huntington’s... Read Post »
Clinical TrialsForte Reports Positive Phase 1b Results for FB102 in Vitiligo Forte Reports Positive Phase 1b Results for FB102 in Vitiligo Read Post »
Clinical TrialsLEO Pharma Reports Positive Phase II TRAPEDS-1 Data Supporting Long-Term Sa... LEO Pharma Reports Positive Phase II TRAPEDS-1 Data Supporting Long-Term Sa... Read Post »
Clinical TrialsFate Therapeutics Wins FDA IND Clearance for FT839 Dual-CAR T-Cell Therapy ... Fate Therapeutics Wins FDA IND Clearance for FT839 Dual-CAR T-Cell Therapy ... Read Post »
Clinical TrialsIpsen Reports Positive Phase III BEOND Results for Dysport in Episodic and ... Ipsen Reports Positive Phase III BEOND Results for Dysport in Episodic and ... Read Post »
Clinical TrialsINmune Bio Reports Early MRI Evidence of XPro Activity in Phase 2 Alzheimer... INmune Bio Reports Early MRI Evidence of XPro Activity in Phase 2 Alzheimer... Read Post »
Clinical TrialsBiocytogen, Whitehawk Partner to Develop Bispecific Antibody-Drug Conjugate... Biocytogen, Whitehawk Partner to Develop Bispecific Antibody-Drug Conjugate... Read Post »
Clinical TrialsBiocon Reports New Phase III Evidence for Yesafili Biosimilar Biocon Reports New Phase III Evidence for Yesafili Biosimilar Read Post »
Clinical TrialsAstraZeneca, Ionis’ Wainua Misses Phase III Endpoint in ATTR-CM Trial AstraZeneca, Ionis’ Wainua Misses Phase III Endpoint in ATTR-CM Trial Read Post »
Clinical TrialsSatellos Reports Interim Phase 2 TRAILHEAD Data: SAT‑3247 Shows Muscle Co... Satellos Reports Interim Phase 2 TRAILHEAD Data: SAT‑3247 Shows Muscle Co... Read Post »
Clinical TrialsRhythm Reports NEJM Publication of IMCIVREE Trial in Hypothalamic Obesity Rhythm Reports NEJM Publication of IMCIVREE Trial in Hypothalamic Obesity Read Post »
Clinical TrialsPrilenia Launches Global Phase 3 PRECISE-HD Trial of Pridopidine for Huntin... Prilenia Launches Global Phase 3 PRECISE-HD Trial of Pridopidine for Huntin... Read Post »
Clinical TrialsUCB Reports Sustained Long‑Term Efficacy of Rozanolixizumab and Zilucopla... UCB Reports Sustained Long‑Term Efficacy of Rozanolixizumab and Zilucopla... Read Post »
Clinical TrialsMAIA Reports 90.5% Disease Control Rate with Ateganosine Plus Cemiplimab in... MAIA Reports 90.5% Disease Control Rate with Ateganosine Plus Cemiplimab in... Read Post »
Clinical TrialsKeenova’s XIAFLEX Delivers Positive Phase 3 Results in Plantar Fibrom... Keenova’s XIAFLEX Delivers Positive Phase 3 Results in Plantar Fibrom... Read Post »
Clinical TrialsSeres Reports Positive SER-155 Results in Immune Checkpoint Enterocolitis Seres Reports Positive SER-155 Results in Immune Checkpoint Enterocolitis Read Post »
Clinical TrialsTurn Therapeutics Reports Interim Phase 2 Results, Finalizes Stage 2 Trial ... Turn Therapeutics Reports Interim Phase 2 Results, Finalizes Stage 2 Trial ... Read Post »
Clinical TrialsCompass Pathways Reports 6-Month Phase 3 Data Showing Durable COMP360 Benef... Compass Pathways Reports 6-Month Phase 3 Data Showing Durable COMP360 Benef... Read Post »
Clinical TrialsTeva Advances TEV-‘408 to Phase 2b After Early Vitiligo Trial Shows R... Teva Advances TEV-‘408 to Phase 2b After Early Vitiligo Trial Shows R... Read Post »
Clinical TrialsHengrui and Kailera’s Oral GLP-1 HRS-7535 Delivers Up to 11.1% Weight... Hengrui and Kailera’s Oral GLP-1 HRS-7535 Delivers Up to 11.1% Weight... Read Post »
